Management of metastatic prostatic carcinoma.
D000315:Adrenalectomy; D003131:Combined Modality Therapy; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007016:Hypophysectomy; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D009919:Orchiectomy; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000532:radiotherapy / Q000628:therapy*
D007987:Gonadotropin-Releasing Hormone; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol; D003534:Cyproterone; D007654:Ketoconazole